ABSTRACT:

Linear IgA bullous dermatosis is a rare subepidermal bullous disease that can occur idiopathically or to be drug-induced. The disease affects both the skin and mucous membranes in children and adults. Drug-induced linear Ig A bullous dermatosis occurs more often in elderly patients who suffer from various chronic and systemic diseases. Among the most frequently reported medications causing the disease are non-steroidal anti-inflammatory drugs, antibiotics, anticoagulants, statins, ACE-inhibitors. In this report, we present a case of etoricoxib-induced linear Ig A bullous dermatosis in a woman with no known comorbidities at the time of hospitalization.

KEYWORDS:

Linear IgA bullous dermatosis, etoricoxib, drug induced dermatosis.

REFERENCES :

1) Lings K, Bygum A. Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark. Acta Derm Venereol 2015; 95: 466–471.
2) Sobjanek M, Sokolowska‐Wojdylo M, Sztaba‐Kania M, Barañska‐Rybak W, Maciejewska A, Wlodarkiewicz A. Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol 2008; 22: 1131.
3) Horiguchi Y, Ikoma A, Sakai R, Masatsugu A, Ohta M, Hashimoto T. Linear IgA dermatosis: Report of an infantile case and analysis of 213 cases in Japan. J Dermatol 2008; 35: 737–743.
4) Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology 2013; 227: 209–213.
5) Adler NR, McLean CA, Aung AK, Goh MSY. Piperacillin‐tazobactam‐induced linear IgA bullous dermatosis presenting clinically as Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap. Clin Exp Dermatol 2017; 42: 299–302.
6) Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B. Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4. PMID: 30511379; PMCID: PMC6379232.
7) Prystowsky S, Gilliam JN. Benign chronic bullous dermatosis of childhood. Linear IgA and C3 deposition on the basement membrane. Arch Dermatol 1976;
8) Gabrielsen TO, Staerfelt F, Thune PO. Drug‐induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereol 1981; 61: 439–441.
9) Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol. 1998 Mar. 110(3):207-10.
10) Sanke S, Kumar A, Chander R. Linear IgA bullous dermatosis induced by diclofenac sodium. Indian J Dermatol Venereol Leprol. 2018 Jul-Aug;84(4):496-497. doi: 10.4103/ijdvl.IJDVL_100_17. PMID: 29667608.
11) Bouldin MB, Clowers-Webb HE, Davis JL, McEvoy MT, Davis MD. Naproxenassociated linear IgA bullous dermatosis: case report and review. Mayo Clin Proc. 2000 Sep;75(9):967-70. doi: 10.4065/75.9.967. PMID: 10994833.